Human kidney organoids reveal the role of glutathione in Fabry disease
Open Access
- 15 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Experimental & Molecular Medicine
- Vol. 53 (10), 1580-1591
- https://doi.org/10.1038/s12276-021-00683-y
Abstract
Fabry disease is an X-linked lysosomal storage disease caused by a mutation in the galactosidase alpha (GLA) gene. Despite advances in therapeutic technologies, the lack of humanized experimental models of Fabry disease has limited the development of new therapies to cure the disease. Herein, we modeled Fabry disease using human inducible pluripotent stem cell (iPSC)-derived kidney organoids and the CRISPR–Cas9 genome-editing system. GLA-mutant human kidney organoids revealed deformed podocytes and tubular cells with accumulation of globotriaosylceramide (Gb3). Ultrastructural analysis showed abundant electron-dense granular deposits and electron-dense lamellate lipid-like deposits that formed concentric bodies (zebra bodies) in the cytoplasm of podocytes and tubules. The oxidative stress level was increased in GLA-mutant kidney organoids, and the increase was accompanied by apoptosis. Enzyme replacement treatment (ERT) with recombinant human α-Gal A decreased the Gb3 accumulation and oxidative stress, which resulted in amelioration of the deformed cellular structure of the GLA-mutant kidney organoids. Transcription profile analyses showed decreased glutathione (GSH) metabolism in GLA-mutant kidney organoids. GSH replacement treatment decreased oxidative stress and attenuated the structural deformity of the GLA-mutant kidney organoids. GSH treatment also increased the expression of podocyte and tubular markers and decreased apoptosis. In conclusion, GLA-mutant kidney organoids derived from human iPSCs are valuable tools for studying the mechanisms and developing novel therapeutic alternatives for Fabry disease.Keywords
This publication has 41 references indexed in Scilit:
- Modulation of oxidative stress responses in the human retinal pigment epithelium following treatment with vitamin CJournal of Cellular Physiology, 2010
- Renal lipid metabolism and lipotoxicityCurrent Opinion in Nephrology and Hypertension, 2010
- 103 Females with X-linked Fabry disease frequently have significant organ involvementMolecular Genetics and Metabolism, 2007
- Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry RegistryJournal of Inherited Metabolic Disease, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- An In Vitro Model of Fabry DiseaseJournal of the American Society of Nephrology, 2005
- Role of glutathione transport processes in kidney functionToxicology and Applied Pharmacology, 2005
- Restoring glutathione as a therapeutic strategy in chronic kidney diseaseNephrology Dialysis Transplantation, 2004
- Natural History of Fabry Renal DiseaseMedicine, 2002
- Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamilyBiochemical Journal, 2001